CD73 alleviates podocytes injury in adriamycin-induced nephrotic syndrome

Yanji Zhu1, Guiling Xie1, Fangyan Qi1

  • 1Department of Pediatrics, People's Hospital of Rizhao, Rizhao 276800, PR China.

Tissue & Cell
|December 5, 2024
PubMed

Insights

Ecto-5'-Nucleotidase (CD73) is upregulated in podocyte injury, contributing to kidney disease. Reducing CD73 expression alleviates inflammation and apoptosis in podocytes, suggesting a protective role.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Podocyte injury is a key factor in kidney disease development.
  • Ecto-5 '-Nucleotidase (CD73) expression increases during podocyte injury, but its role remains unclear.

Purpose of the Study:

  • To investigate the function of CD73 in podocyte injury.
  • To determine if CD73 modulates inflammation and apoptosis in podocytes.

Main Methods:

  • Adriamycin (ADR) was used to induce podocyte injury in a mouse podocyte cell line (MPC5).
  • CD73 expression was downregulated using lentivirus-transfected shRNA.
  • Levels of cytokines (IL-1β, IL-18), apoptosis, and apoptosis-related proteins (Bax, Caspase-3, Desmin) were measured.

Main Results:

  • ADR treatment significantly increased CD73, IL-1β, IL-18, apoptosis rate, and Bax, Caspase-3, and Desmin expression.
  • Downregulating CD73 in ADR-treated podocytes markedly reduced IL-1β, IL-18, apoptosis, and the expression of Bax, Caspase-3, and Desmin.

Conclusions:

  • CD73 plays a role in podocyte injury.
  • Reducing CD73 expression alleviates podocyte damage by decreasing inflammation and apoptosis.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...